M01AX05 - Glucosamine |
Not porphyrinogenic |
NP |
Rationale
No CYP-dependent metabolism.
Chemical description
Relatively small and water-soluble molecule (MW 179)
Therapeutic characteristics
Endogenous substance that possibly works by a positiv influence on cartilage metabolism. Common adverse reactions that can be mistaken for porphyria symptoms are dyspepsia, stomach ache, diarrhoea, constipation, nausea.
Hepatic exposure
Significant
Metabolism and pharmacokinetics
Metabolized mainly by the hexosamine-system and thereby independent of the cytopchrome P-450 system (1).
Preclinical data
None
Personal communication
None
Published experience
None
IPNet drug reports
Uneventful use reported in 28 patients with acute porphyria.
References
- Summary of Product Characteristics
- 1) SPC glucosamine (updated: 2007-12-20). #2385
Similar drugs
© NAPOS 2024